KetoVie

Cambrooke Therapeutics is a leader and global innovator in the field of advanced medical nutrition in the areas of inborn errors of metabolism and new to ketogenic diet therapy. Cambrooke Therapeutics recognizes the critical nature of managing serious medical disorders through medically based nutrition therapies. For people with serious unmet medical nutrition needs, it is a daily challenge to find flavorful, easy options that can sustain their diets and maintain their nutritional needs. Cambrooke Therapeutics (expansion of Cambrooke Foods) was founded in 2000 by Lynn and David Paolella, the parents of two children diagnosed with a rare disease called phenylketonuria (PKU). PKU is one of the few genetic diseases, which is managed almost entirely with nutritional intervention. The Paolellas’ goal in forming Cambrooke was simple - to develop improved nutritional therapeutic options for those with serious medical disorders. Today, Cambrooke produces medical formulas and foods for the management of a variety of medical conditions and we continue to innovate new nutritional options targeted at a wide array of diseases. Our newest innovation is KetoVie: KetoVie 4:1 ready-to use liquid is a medical food for the dietary management of intractable epilepsy and other disorders where a ketogenic diet is indicated. KetoVie Café is a family of low carbohydrate convenient ketogenic friendly foods which may be incorporated into the diets of individuals following ketogenic diets.